Health & Medicine Week articles from September 2003

Health & Medicine Week archives from September 2003

Relationship-based intervention improves maternal sensitivity in young mothers.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Relationship-based intervention improves maternal sensitivity in young mothers. According to recent research from Germany, "Adolescent mothers and their infants are a high-risk group. They are...

Carnegie Mellon develops new process for growing bone.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Carnegie Mellon University's Jeffrey Hollinger and his research team will receive $1.12 million over the next 4 years from the U.S. National Institutes of Health (NIH) to develop a new therapy for...

Brain scans, blood tests show positive effects of meditation.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- People who underwent 8 weeks of meditation training produced more antibodies to a flu vaccine and showed signs of increased activity in areas of the brain related to positive emotion than individuals...

Women benefit from physical activity during and after menopause.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Women typically reach menopause in their early 50s. Fluctuations in hormonal levels and cycles can make this a time of profound emotional and physical changes for many women. It's also a time when a...

Physical activity definitions broadened to include daily activities.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Even moderate types of exercise provide health benefits. For that reason, a state-based survey, conducted by the U.S. Centers for Disease Control and Prevention (CDC) for the first time includes a...

Prevalence of HIV infection increasing in older Americans.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- The prevalence of HIV infection is increasing among older Americans. According to a study from the United States, "In the past 11 years, the cumulative number of AIDS cases reported to the Centers...

Hypnosis doesn't improve pain relief strategies.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Techniques like relaxation and visualizing a pleasant scene can take the sting out of mild pain, but adding hypnosis to the mix does not make such techniques more effective, according to a new report....

Targeting TNF pathway along with ATRA may represent route to treat leukemias.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Targeting TNF pathway along with ATRA may represent route to treat leukemias. According to a study from Canada, "The nuclear receptor ligand all-trans retinoic acid (ATRA) causes dramatic terminal...

Biomaterials company receives U.S. patent on polymer technology.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Life Medical Sciences, Inc., (CHAI) announced that it has been issued a patent covering novel resorbable polymeric materials exhibiting reverse thermal gelation properties that may be used in a variety...

Polysaccharide extracts from different algae produce different immune effects.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Polysaccharide extracts from different microalgae produce differing immune effects, but both act as anti-inflammatory agents. According to published research from Spain, "Crude polysaccharide...

Mast cell product-antagonizing is short-term treatment, long-term solutions needed.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Allergic rhinitis treatment has been short term, based on mast cell product reduction; soon longterm therapy may be possible. "Mast cells not only function as effector cells, but also influence...

Rhinitis immunotherapy using specific subcutaneous allergen is better than drugs.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Allergic rhinitis may be treated and reduced by subcutaneous allergen specific immunotherapy, instead of drugs. According to recent research from Denmark, "Allergen-specific immunotherapy in the...

Latex allergy may create cross-reactive fruit allergies; kiwi is highest risk.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Patients with allergy to latex should be warned of possible crossreactivity with some fruits; kiwi, banana, avocado being the greatest risk. "Since the first case reported in 1927, latex allergy has...

Protein digestibility related to allergenicity.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Protein digestibility is related to allergenicity, according to a report in a recent issue of Environmental Health Perspectives. "In January 2001 a Joint Food and Agriculture Organization of the...

As U.S. population ages, AD prevalence expected to increase substantially.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- The number of people with Alzheimer disease (AD) in the United States will continue to increase unless new discoveries are made to prevent this illness, according to a new report. Because AD places...

Regulation of glucose by HIF-1 protects neurons from amyloid beta peptide.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- The regulation of glucose metabolism by HIF-1 mediates a neuroprotective response to amyloid beta peptide. According to recent research from the United States, "It is frequently argued that both...

Catalytic antioxidant, AEOL 10150, selected for development as ALS treatment.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Incara Pharmaceuticals Corp. (INCR) announced the selection of its catalytic antioxidant, AEOL 10150, for late-stage preclinical development to support an investigational new drug (IND) application for...

Rights acquired to ALS gene therapy from Salk Institute.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Ceregene, Inc., announced that it has signed an option agreement with the Salk Institute for Biological Studies for exclusive worldwide rights to its amyotrophic lateral sclerosis (ALS) gene therapy...

Progress reported on Cellegesic phase III trial.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Cellegy Pharmaceuticals, Inc., (CLGY) announced that it has made considerable progress with a new 150-patient phase III clinical trial with Cellegesic (nitroglycerin ointment) for the treatment of pain...

Seniority of surgeon did not affect aneurysm surgery outcome.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- The seniority of the surgeon performing aneurysm repair, among registrars, senior registrars, and consultants, did not affect the outcome of the operation. "Specialist surgical registrars perform...

Research hampered by shortage of monkeys.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- A nationwide shortage of rhesus macaque monkeys is hampering efforts to create cures from new information such as the human genome sequence, organ transplant techniques, and the use of stem cells to...

Genes showing differential expression in anorexia mutant mouse identified.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Genes showing differential expression in the anorexia mutant mouse model have been identified. According to published research from South Korea, "Differential display (DID) PCR was applied to...

Novel 1,3,4-trisubstituted pyrazole derivatives stifle tumor growth mechanisms.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Novel 1,3,4-trisubstituted pyrazole derivatives stifle tumor growth mechanisms. According to recent research published in the journal Chemical & Pharmaceutical Bulletin, "several...

Resistance may occur in bacteria if innate antibiotic proteins are used.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- There may be a risk involved in use of innate antibiotic molecules against bacterial infection. According to a study from Canada, "A remarkable range of novel antibiotics is attracting increasing...

Newly discovered inhibitors of bacterial lactamases may prevent resistance.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- The most important antibiotics in general use today are the b-lactam family of products, but the medical community faces a serious problem with these antibiotics: the increasing development of drug...

World Health Organization: Farmers should cut antibiotic use.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Farmers worldwide should take a lesson from Danish bacon producers and reduce the use of antibiotics on their livestock to help stem the growth of drug-resistant bacteria in humans, the U.N. health...

N- and C-terminal modifications of negamycin affect antibacterial activity.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- N- and C-terminal modifications of negamycin affected the drug's antibacterial activity. "Negamycin 1 is a bactericidal antibiotic with activity against Gram-negative bacteria, and served as a...

Swiss pharmaceutical group announces European drug submission for palonosetron.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Helsinn Healthcare, SA, a privately owned Swiss pharmaceutical group, announced the submission of their European drug application for palonosetron through the centralized procedure that will lead to the...

Gallerimycin, a moth-derived antifungal peptide, isn't active against yeast.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- A new antifungal discovered in wax moth, gallerimycin, is not active against yeast. According to published research from Germany, "A novel defensin-like peptide was identified in the greater wax...

TSLC1 gene in human lung cancer is probably a cell adhesion molecule.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- The mouse ortholog of TSLC1, a tumor suppressor gene in human lung cancer, is found to be a cell adhesion molecule that may be expressed more to slow metastasis. According to recent research from...

Vancomycin-resistant infections are low among liver transplant candidates.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Vancomycin-resistant infections are low among liver transplant candidates. "The orthotopic liver transplant (OLT) population has been particularly affected by the increase in vancomycin-resistant...

Egr-1 inhibition reverses the transformation of prostate cancer cells.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Egr-1 inhibition reverses the transformation of prostate cancer cells. According to recent research published in the journal Oncogene, "transcription factor early growth response-1 (Egr-1) is a...

New MAST technology has universal applications for tracking desired mRNA sites.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- New MAST technology has universal applications for tracking desired mRNA sites. "A solution-based method, mRNA accessible site tagging (MAST), has been developed to map the accessible sites of any...

Novel DSTP derivative inhibits growth of HIV and herpesviruses.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- A novel DSTP derivative strongly inhibits the cellular activity of HIV and a variety of herpesviruses. According to a study from Germany, "N,N'-bisheteryl derivatives of dispirotripiperazine (DSTP)...

Several factors contribute to treatment failure in chronic hepatitis C.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Several factors contribute to treatment failure in chronic hepatitis C. "The treatment of chronic hepatitis C is currently based on a combination of pegylated interferon (IFN)-alpha and ribavirin....

Researchers close in on scientific definition of arousal.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- For scientists in the field of neurobiology, defining the factors that influence the arousal of brain and behavior is a holy grail. Research published by Rockefeller University scientists in the...

Ventracor reports on first patient.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Medical investigators have provided a progress report on the pilot trial of Ventracor's artificial heart being conducted at the Alfred Hospital in Melbourne. Chief medical investigators Professor...

Airway epithelium is in constant repair; allergens create cyclic Th2 response.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Asthmatic airway epithelium is in constant repair mode, and a cycle of Th2 responses due to contact with environmental allergens. "Epithelial cells in the airway wall actively interact with...

Biomedical engineer receives $1.8 million grant to study lung damage.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- University of California Irvine biomedical engineer Steven C. George, who is one of the first U.S. scientists to create three-dimensional living lung tissue, has received a $1.8 million grant from the...

Disodium chromoglycate doesn't help kids with asthma.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- After 35 years of use, advice has changed and doctors are no longer recommended to prescribe disodium cromogycate (DSCG) to children with asthma. New research, just published in The Cochrane...

Food allergy may be a source to consider for asthma of unknown origin.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Although rare, foods may be a source to investigate in asthma of unknown origin; blinded food challenges can prove it. According to a study from the United States, "Food allergy may present with a...

Labeling changes required for drug products that contain salmeterol.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration (FDA) is announcing the addition of new safety information and warnings to the labeling for drug products that contain salmeterol, a long-acting bronchodilator used...

Patent awarded for therapeutic uses of interleukin-9 receptor protein.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Genaera Corp. (GENR) announced issuance by the United States Patent and Trademark Office of patent number 6,602,850 covering the use of certain soluble human interleukin-9 (IL-9) receptor protein...

Revotar reports positive results with small molecule selectin antagonist.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Encysive Pharmaceuticals (ENCY) announced its majority-owned German affiliate, Revotar Biopharmaceuticals, AG, reported positive results with bimosiamose in a 12-patient, double-blind, cross-over,...

Study links preschool snoring, asthma, and nighttime cough.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Preschool-age children who regularly snore have a higher prevalence of asthma and nighttime cough than children who do not snore, says a new study. The study found that preschool children who snored...

Study of glucocorticoid-receptor interactions may lead to new anti-asthma agents.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Studies on the binding of glucocorticoids to the receptor and subsequent activity may lead to new and better anti-asthma agents. "Glucocorticoids are widely used to treat inflammatory and immune...

Nramp gene determines efficacy of mycobacteria-based asthma treatment.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- The human Nramp gene determines the efficacy of mycobacteria-based asthma treatment. "Genes controlling antibacterial resistance may be important in the hygiene hypothesis, which states that lack of...

Patient enrollment completed in phase IIb CART-2 study with AGI-1067.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- AtheroGenics, Inc., (AGIX) has recently completed enrollment in a phase IIb clinical trial evaluating its proprietary v-protectant drug candidate, AGI-1067, as a treatment for atherosclerosis and...

Vitamins restore blood vessel performance in kids with high cholesterol.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Moderate doses of vitamins C and E can slow progression of atherosclerosis in children with a genetic predisposition to high cholesterol, according to new research. This is the first randomized...

FDA approves skin emulsion.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Sinclair Pharmaceuticals Ltd. has received U.S. Food and Drug Administration registration (510k) for Atopiclair as the first prescription emulsion designed to relieve the symptoms of atopic dermatitis,...

First patient dosed in phase III atrial arrhythmia studies.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Cardiome Pharma Corp. announced that it has commenced patient dosing in its initial phase III efficacy study of RSD1235 for the acute treatment of atrial fibrillation. The initial study, called ACT...

Array analysis of autoimmune disease leads to vaccine development.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Researchers have developed protein arrays that could be used to diagnose autoimmune diseases, such as multiple sclerosis, earlier than is currently possible. The approach, described in the...

Autoreactive B lymphocytes may be removable by recombinant fusion proteins.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Autoantigen Fcgamma1 fusion proteins appear to selectively eliminate autoreactive B lymphocytes. According to a study from Germany, "Antigen-specific B cells are key players in many autoimmune...

Some MG seronegative patients may be MuSK antibody positive.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- MG seronegative patients may be atypical and some can be identified by MuSK antibody positivity. "Serum antibodies to muscle specific receptor tyrosine kinase (MuSK) were detected in 12/32 patients...

Systemic lupus erythematosus is more prevalent than was previously thought.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Lupus is more prevalent than previously thought, but many testing positive for the disease have milder cases. "Systemic lupus erythematosus (SLE) is the most diverse of the autoimmune diseases...

Targeted DNA vaccine may reverse disease.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Stanford University Medical Center researchers have developed a way to tailor therapies to combat the specific inappropriate responses of autoimmune diseases in mice. The researchers also have shown...

Efficient Vav3 translocation to B cell membrane rafts requires Grb2 and BLNK.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Vav3 requires Grb2 and BLNK to translocate efficiently to membrane rafts. According to published research from Japan, "Despite the importance of the Vav family proteins for B cell receptor (BCR)...

Can effective stress management prevent back injuries in nurses?
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- A University of Florida nursing researcher is examining whether stress and pain management techniques can prevent work-related injuries and improve the overall health of nursing professionals,...

Proteinases secreted by Bacillus intermedius during sporulation studied.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Proteinases secreted by Bacillus intermedius in the late stages of sporulation have been investigated. According to published research from Russia, "In the late stages of sporulation, cells of...

FDA approves Photofrin for the ablation of high-grade dysplasia.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Axcan Pharma, Inc., announced that it has received approval from the U.S Food and Drug Administration (FDA) for the use of Photofrin photodynamic therapy (PDT) in the ablation of high-grade dysplasia...

Breast cancer, metastasis, growth reduced with i.v. bee venom therapy in murine model.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- In a mouse breast cancer model, intravenous but not intradermal bee venom reduced metastasis to lung. According to published research from Croatia, "The possible tumor growth-inhibiting and...

Drug may eliminate transfusions in patients with blood disorder.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- The use of hydroxyurea may eliminate the need for future blood transfusions in children with beta-thalassemia major, an inherited blood disorder, according to a new study. Beta-thalassemia occurs...

Symptoms, cirrhosis disease progression are known; cause and cure remain elusive.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Some of the symptoms and disease progression are known for primary biliary cirrhosis, but the cause and cure, other than liver transplant, remain elusive. According to published research from the...

Percutaneous transhepatic retrieval of a displaced biliary stent is feasible.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Percutaneous transhepatic retrieval of a displaced biliary stent is feasible. According to a study from Germany, "Biliary stents play an important role in the treatment of jaundice due to malignant...

A novel skin model invites new ways to explore angiogenesis in vitro.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- A novel skin model invites new ways to explore angiogenesis in vitro. "We have previously shown that reconstructed human skin engineered from autologous keratinocytes, fibroblasts, and sterilized...

Hybrid fermentation devices increase the output of recombinant molecules.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Hybrid fermentation devices increase the output of recombinant molecules. "Fermentations employing genetically modified (recombinant) bacteria have complex metabolisms that are sensitive to the...

New screening for CAR reveals transfection efficiency in cancer cells.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- According to published research from the United States, "virus uptake is the first rate-limiting step for the successful gene delivery of any virus-based gene therapy. For adenovirus-based gene therapy,...

Dopamine receptor genotype doesn't affect TSD efficacy for bipolar patients.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Dopamine receptor genotype doesn't affect the efficacy of total sleep deprivation (TSD) for bipolar patients. According to published research from Italy, TSD "is an effective treatment for mood...

All donations now screened for West Nile in U.S.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- This year, every blood donation collected in the United States is being screened for West Nile virus, according to a U.S. Centers for Disease Control and Prevention (CDC) update in Morbidity and...

FDA license granted for new HIV test kit.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Bio-Rad Laboratories, Inc., (BIO, BIO.B) has received a license from the U.S. Food and Drug Administration for its HIV-1/HIV-2 PLUS O EIA test kit used for diagnostic testing and the screening of blood...

Diffusion-weighted imaging can detect bone marrow alterations.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Diffusion-weighted imaging can detect bone marrow alterations. "Diffusion-weighted imaging allows for measurement of tissue microstructure and reflects the random motion of water protons,"...

Antithymocyte globulin lowers GVHD, worsens T-cell deficiency.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Antithymocyte globulin therapy in bone marrow transplant recipients lowers incidence of graft versus host disease, but extends the time of severe T cell deficiency. "The effect of antithymocyte...

Collagen-hydroxyapatite/tricalcium phosphate microspheres deliver rhTGF-beta 1.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Collagen-hydroxyapatite/tricalcium phosphate microspheres deliver rhTGF-beta 1 for bone regeneration. "The purpose of this study is to evaluate the carrier capability of...

Nuclear medicine bone scan can give a potentially misleading appearance.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Nuclear medicine bone scan can give a potentially misleading appearance. According to a study from the United States, "Nuclear medicine bone scan is an essential diagnostic imaging tool both for the...

Rotationplasty may be an effective partial limb salvage procedure.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Rotationplasty may be an effective partial limb salvage procedure. According to a study from South Korea, "In patients having malignant or aggressive bone tumors around the knee joint and requiring...

Zoledronic acid will improve patients' quality of life.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Zoledronic acid will improve patients' quality of life. "The two main therapeutic applications of bisphosphonates are tumor bone disease and osteoporosis," researchers in Belgium report. "They...

Seropositive schizophrenic patients respond to cerebrospinal fluid filtration.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Therapy resistant schizophrenia or affective spectrum psychosis patients positive for Borna disease virus antibodies do respond to cerebrospinal fluid filtration. "According to previous...

Company plans to increase sales of I-Plant prostate cancer seed.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Implant Sciences (IMX) announced that they will initiate a direct marketing and sales program to sell their I-Plant Seed brachytherapy seeds for use in the treatment of prostate cancer. This...

Welsh study set to accelerate search for new treatment.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Artificially creating brain cancer cells by manipulating normal brain cells in the lab could pave the way to new treatments for the disease, a Cancer Research UK study reveals. Using human brain...

Research: GliaSite RTS is a safe and effective treatment for brain tumors.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Proxima Therapeutics, Inc., a developer of site-specific radiation therapy systems for brain and breast cancer, announced publication of data from a multicenter study of its GliaSite Radiation Therapy...

Breast cancer screening should be encouraged by general practitioners.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Breast cancer screening should be encouraged by general practitioners. "Achieving and maintaining a high rate of attendance for screening and two-yearly rescreening is essential for the success of...

Duke University's hyperthermia treatment acquired.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Celsion Corporation has obtained exclusive rights to an advanced phased array radio frequency (RF) heating system designed specifically for use with chemotherapeutic drugs for the treatment of locally...

First component of rolling NDA submitted for RSR13.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Allos Therapeutics, Inc., (ALTH) announced that it has begun submission of a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for the company's investigational radiation...

Program for low-income women suggests vital importance of access to screening.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Low-income women participating in an Oregon breast cancer screening program had a higher incidence of breast cancer than women in other screening programs, according to Oregon Health & Science...